Phase Ii study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia
Abrams, R.A.; Hanson, G.; Hansen, R.M.; Anderson, T.
Cancer Treatment Reports 70(4): 535
1986
ISSN/ISBN: 0361-5960 PMID: 3754490 Document Number: 270108
Document emailed within 1 workday
Related Documents
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880Sanz, G.F.; Sanz, M.A.; Rafecas, F.J.; Martínez, J.A.; Martín-Aragonés, G.; Marty, M.L. 1986: Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia Cancer Treatment Reports 70(11): 1321-1323
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Okamoto, T.; Kanamaru, A.; Shimazaki, C.; Motoji, T.; Takemoto, Y.; Takahashi, M.; Fukushima, T.; Takeshita, A.; Kusumoto, G.S.; Kishimoto, Y.; Yorimitsu, S.; Tsukuda, K.; Uike, N.; Arima, N.; Ohno, R. 2000: Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis International Journal of Hematology 72(2): 200-205
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Kobayashi, T.; Ogawa, M.; Kuraishi, Y.; Nagata, T.; Aiba, K.; Nakamura, T.; Usui, N.; Yamazaki, H.; Ichiba, K.; Isogai, Y. 1988: DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(5): 855-863
Ciuleanu, T.E.; Curcă, R.; Iancu, D.; Todor, N.; Cebotaru, C.; Radulescu, I.; Banu, E.; Ghilezan, N. 2002: First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. a phase Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 7(1): 43-46
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Hirota, T.; Takeuchi, M.; Iwata, A.; Kitagawa, S.; Sato, T.; Konno, K.; Sawada, K.; Kobayashi, S.; Hamaguchi, N.; Agata, H.; Katano, N.; Fujimoto, T. 1998: Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 385-390
Takano, M.; Goto, T.; Hirata, J.; Furuya, K.; Horie, K.; Takahashi, M.; Yokota, H.; Kino, N.; Kudoh, K.; Kikuchi, Y. 2013: UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study European Journal of Gynaecological Oncology 34(2): 120-123
Omura, G.A.; Vogler, W.R.; Smalley, R.V.; Maldonado, N.; Broun, G.O.; Knospe, W.H.; Ahn, Y.S.; Faguet, G.B. 1977: Phase Ii Study of beta-2'-deoxythioguanosine in adult acute leukemia Cancer Treatment Reports 61(7): 1379-1381
Weiss, M.A. 1997: Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL) Leukemia 11(Suppl): S28-S30
Hayakawa, M.; Morise, K.; Oka, Y.; Saito, H. 1987: Combination chemotherapy of UFT, etoposide and CDDP in advanced gastric cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(7): 793-798
Creagan, E.T.; Ahmann, D.L.; Schutt, A.J.; Green, S.J. 1982: Phase Ii study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma Cancer Treatment Reports 66(6): 1425-1426
Kunisaki, C.; Takahashi, M.; Nagahori, Y.; Makino, H.; Takagawa, R.; Sato, T.; Oshima, T.; Fujii, S.; Kosaka, T.; Ono, H.A.; Akiyama, H.; Shimada, H. 2008: Phase i study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer Anticancer Research 28(4c): 2473-2478